These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3237679)

  • 1. Reshaping the antibody combining site by CDR replacement--tailoring or tinkering to fit?
    Cheetham J
    Protein Eng; 1988 Sep; 2(3):170-2. PubMed ID: 3237679
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-combining sites. Extending the natural limits.
    Webster DM; Pedersen J; Staunton D; Jones A; Rees AR
    Appl Biochem Biotechnol; 1994; 47(2-3):119-32; discussion 132-4. PubMed ID: 7944332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering the binding site of an antibody against N-glycolyl GM3: from functional mapping to novel anti-ganglioside specificities.
    Rojas G; Pupo A; Gómez S; Krengel U; Moreno E
    ACS Chem Biol; 2013 Feb; 8(2):376-86. PubMed ID: 23138862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the evolution of an antibody combining site.
    Wedemayer GJ; Patten PA; Wang LH; Schultz PG; Stevens RC
    Science; 1997 Jun; 276(5319):1665-9. PubMed ID: 9180069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and dynamics of the anti-AMCV scFv(F8): effects of selected mutations on the antigen combining site.
    Arcangeli C; Cantale C; Galeffi P; Rosato V
    J Struct Biol; 2008 Oct; 164(1):119-33. PubMed ID: 18662789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of optical biosensors from chemisynthetic antibody libraries.
    Jespers L; Bonnert TP; Winter G
    Protein Eng Des Sel; 2004 Oct; 17(10):709-13. PubMed ID: 15537669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach for rapidly reshaping single-chain antibody in vitro by combining DNA shuffling with ribosome display.
    Wang XB; Zhou B; Yin CC; Lin Q; Huang HL
    J Biochem; 2004 Jul; 136(1):19-28. PubMed ID: 15269236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of the combining site in a humanized anti-Tac antibody.
    Glaser SM; Vásquez M; Payne PW; Schneider WP
    J Immunol; 1992 Oct; 149(8):2607-14. PubMed ID: 1401898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of residues in the monoclonal antitumor antibody L6 important for binding to its tumor antigen.
    Stenzel-Johnson PR; Yelton D; Bajorath J
    Biochemistry; 1994 Dec; 33(48):14400-6. PubMed ID: 7526900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent rearrangement in an antigen-antibody interface introduced by site-directed mutagenesis of the antibody combining site.
    Ysern X; Fields BA; Bhat TN; Goldbaum FA; Dall'Acqua W; Schwarz FP; Poljak RJ; Mariuzza RA
    J Mol Biol; 1994 May; 238(4):496-500. PubMed ID: 8176740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of shape variations in the antibody binding site by molecular dynamics computer simulation.
    de la Cruz X; Mark AE; Tormo J; Fita I; van Gunsteren WF
    J Mol Biol; 1994 Mar; 236(4):1186-95. PubMed ID: 8120895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of nucleophiles and spectroscopic probes into antibody combining sites.
    Pollack SJ; Nakayama GR; Schultz PG
    Science; 1988 Nov; 242(4881):1038-40. PubMed ID: 3194752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the energetics of an antibody-antigen interface by alanine shaving and molecular grafting.
    Jin L; Wells JA
    Protein Sci; 1994 Dec; 3(12):2351-7. PubMed ID: 7538848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-binding site protection during radiolabeling leads to a higher immunoreactive fraction.
    Van den Abbeele AD; Aaronson RA; Daher S; Taube RA; Adelstein SJ; Kassis AI
    J Nucl Med; 1991 Jan; 32(1):116-22. PubMed ID: 1988614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.
    Yang WP; Green K; Pinz-Sweeney S; Briones AT; Burton DR; Barbas CF
    J Mol Biol; 1995 Dec; 254(3):392-403. PubMed ID: 7490758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding differences between synthetic and natural antibodies can help improve antibody engineering.
    Burkovitz A; Ofran Y
    MAbs; 2016; 8(2):278-87. PubMed ID: 26652053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody--hapten interactions in solution.
    Dwek RA; Jones R; Marsh D; McLaughlin AC; Press EM; Price NC; White AI
    Philos Trans R Soc Lond B Biol Sci; 1975 Nov; 272(915):53-74. PubMed ID: 1818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.